U.S. Hemostasis & Tissue Sealing Agents Market (By Product: Topical Hemostat, Adhesive & Tissue Sealant) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The U.S. hemostasis & tissue sealing agents market size was estimated at around USD 2.31 billion in 2023 and it is projected to hit around USD 5.45 billion by 2033, growing at a CAGR of 8.97% from 2024 to 2033.

Key Pointers

• By Product, the topical hemostat segment held the largest revenue share of 66% in 2023.
• By Product, the adhesive and tissue sealant segment is expected to expand at the highest CAGR from 2024 to 2033.

U.S. Hemostasis & Tissue Sealing Agents Market Overview

The U.S. hemostasis and tissue sealing agents market is witnessing significant growth driven by advancements in medical technology, rising surgical procedures, and increasing awareness about the benefits of these products. Hemostasis and tissue sealing agents play a crucial role in controlling bleeding and promoting wound healing, thereby improving patient outcomes and reducing healthcare costs.

U.S. Hemostasis & Tissue Sealing Agents Market Growth Factors

The growth of the U.S. hemostasis and tissue sealing agents market is driven by the technological advancements in the development of innovative hemostatic agents and tissue sealants with improved efficacy and safety profiles are driving market expansion. Furthermore, the escalating number of surgical procedures, fueled by the rising prevalence of chronic diseases and the aging population, has significantly increased the demand for these products across various medical specialties. Moreover, heightened awareness among healthcare professionals and patients regarding the benefits of hemostasis and tissue sealing agents in minimizing bleeding and enhancing surgical outcomes has contributed to their widespread adoption. Additionally, the expanding applications of these agents in minimally invasive procedures, trauma management, and wound care are further propelling market growth. Despite challenges such as stringent regulatory requirements and high costs, manufacturers are actively focusing on research and development endeavors to introduce safer and more cost-effective solutions to meet the growing demand in the market.

U.S. Hemostasis & Tissue Sealing Agents Market Trends:

• Increased Surgical Procedures: The market is witnessing a surge in surgical procedures, driven by factors such as the aging population and the rising prevalence of chronic diseases, thereby boosting the demand for hemostasis and tissue sealing agents.
• Growing Adoption of Minimally Invasive Procedures: There is a notable trend towards minimally invasive procedures, and as a result, there is an increased demand for hemostasis and tissue sealing agents that are suitable for use in these procedures.
• Rising Awareness and Education: Healthcare professionals and patients are becoming increasingly aware of the benefits of hemostasis and tissue sealing agents in reducing bleeding complications and improving surgical outcomes, leading to greater adoption of these products.
• Expanding Applications: Hemostasis and tissue sealing agents are finding new applications beyond traditional surgical settings, including trauma management, wound care, and interventional procedures, driving market growth.
• Shift towards Synthetic Sealants: There is a growing preference for synthetic sealants over traditional methods such as sutures and clips due to their ease of use, effectiveness, and reduced risk of infection.
• Focus on Research and Development: Manufacturers are investing heavily in research and development activities to introduce novel products with improved properties, including faster hemostasis, stronger tissue adherence, and biocompatibility.

Product Insights

In 2023, the topical hemostat segment dominated the market with a significant share of 66%. Typically used in conjunction with conventional treatment methods, these hemostats offer minimal tissue reactivity, quick absorption, non-antigenicity, and cost-effectiveness. They are categorized into mechanical, active, and flowable types, comprising materials such as polyethylene glycols, porcine gelatin, cellulose, and collagen.

The adhesive and tissue sealant segment is projected to witness substantial growth during the forecast period, given its crucial role in managing blood loss during surgeries. This segment is further divided into synthetic, natural, and adhesion barrier subcategories. Factors driving their demand over sutures include faster procedural rates, minimal invasiveness, reduced post-surgical infections, and prevention of fluid exudation from the body.

U.S. Hemostasis & Tissue Sealing Agents Market Key Companies:

• Johnson & Johnson
• CryoLife Inc
• Advance Medical Solution (AMS) Group Plc.
• Cohera Medical Inc.
• Integra Life Sciences Corporation
• Pfizer Inc.
• BD
• Baxter
• HyperBranch Medical Technology
• Biomet Inc
• B Braun Medical Inc
• Smith & Nephew

Recent Developments

• In March 2023, Advamedica obtained FDA 510(k) clearance for its Ax-Surgi surgical hemostat. This biopolymer-based device is designed for effectively controlling severe surgical bleeding.
• In December 2022, Integra LifeSciences announced the successful acquisition of Surgical Innovation Associates (SIA), marking a significant step towards its goal of becoming a global leader in surgical innovation. This acquisition reaffirms Integra's commitment to advancing surgical techniques and technologies.

U.S. Hemostasis & Tissue Sealing Agents Market Segmentations:

By Product

• Topical Hemostat
  • Active
  • Mechanical
  • Flowable
• Adhesive & Tissue Sealant
  • Synthetic Tissue Sealant
  • Natural Tissue Sealant
  • Adhesion Barrier Products